Abstract
Transcriptional silencing by CpG island hypermethylation of gene regulatory regions is one mechanism for inactivation of tumour suppressor genes. Chromosome 9q deletion is frequently found in transitional cell carcinoma (TCC) of the bladder and upper urinary tract and one of the putative tumour suppressor loci has been mapped to 9q32-33. A gene designated as DBCCR1 was identified in the candidate region and its mRNA expression is thought to be suppressed by hypermethylation. To understand the role of hypermethylation in TCC, we evaluated the methylation status of 20 CpG sites of the DBCCR1 5′-CpG island region in a total of 69 tumours from 45 patients, 21 normal urothelial specimens, and six bladder cancer cell lines. Aberrant hypermethylation levels were found in 36 (52%) of 69 tumours without any association with tumour grade or stage. Methylation was weakly detected in the normal urothelium in association with ageing. Although recurrent tumours tended to have higher methylation levels than the initial tumours, the methylation pattern was mostly maintained between multifocal TCCs in individual patients. The results suggest that hypermethylation of the DBCCR1 region is one of the earliest alterations in the development of TCCs and there may be an age-related hypermethylation-based field defect in normal urothelium. Methylator or methylation-resistant phenotype seems to be maintained during multifocal development or recurrence of most TCCs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ahuja N, Li Q, Mohan AL, Baylin SB and Issa JP. . 1998 Cancer Res. 58: 5489–5494.
Ceder H and Razin A. . 1990 Biochem. Biophys. Acta. 1049: 1–8.
Choi EK, Uyeno S, Nishida N, Okumoto T, Fujimura S, Aoki Y, Nata M, Sagisaka K, Fukuda Y, Nakao K, Yoshimoto T, Kim YS and Ono T. . 1996 Mutat. Res. 354: 123–128.
Cross SH and Bird AP. . 1995 Curr. Opin. Genet. Dev. 5: 309–314.
Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL and Paul CL. . 1992 Proc. Natl. Acad. Sci. USA 89: 1827–1831.
Gardiner-Garden M and Frommer M. . 1987 J. Mol. Biol. 196: 261–282.
Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM and Jones PA. . 1995 Cancer Res. 55: 4531–4535.
Habuchi T, Devlin J, Elder PA and Knowles MA. . 1995 Oncogene 11: 1671–1674.
Habuchi T, Yoshida O and Knowles MA. . 1997 Hum. Mol. Genet. 6: 913–919.
Habuchi T, Luscombe M, Elder PA and Knowles MA. . 1998 Genomics 48: 277–288.
Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan D-SR, Gnarra JR, Linehan WM and Baylin SB. . 1994 Proc. Natl. Acad. Sci. USA 91: 9700–9704.
Herman Jg, Merlo A, Mao L, Lapidus RG, Issa J-PJ, Davidson NE, Sidransky D and Baylin SB. . 1995 Cancer Res. 55: 4525–4530.
Hsieh C-H. . 1994 Mol. Cell. Biol. 14: 5487–5494.
Issa J-P, Ottaviano YL, Celano P, Hamilton SR, Davidson NE and Baylin SB. . 1994 Nature Genet. 7: 536–540.
Issa J-P, Vertino PM, Boehm CD, Newsham IF and Baylin SB. . 1996 Proc. Natl. Acad. Sci. USA 93: 11757–11762.
Issa J-P, Zehnbauer BA, Kaufmann SH, Biel MA and Baylin SB. . 1997 Cancer Res. 57: 1678–1681.
Issa J-P. . 1999 Crit. Rev. Oncol. Hematol. 2: 31–43.
Jones PA. . 1996 Cancer Res. 56: 2463–2467.
Jones PA. . 1999 Trends Genet. 15: 34–37.
Jones PA and Laird PW. . 1999 Nature Genet. 21: 163–166.
Knowles MA, Elder PA, Williamson M, Cairns JP, Shaw ME and Law MG. . 1994 Cancer Res. 54: 531–538.
Li Q, Jedlicka A, Ahuja N, Gibbons MC, Baylin SB, Burger PC and Issa J-PJ. . 1998 Oncogene 16: 3197–3202.
Maesawa C, Tamura G, Nishizuka S, Ogasawara S, Ishida K, Terashima M, Sakata K, Sato N, Saito K and Satodate R. . 1996 Cancer Res. 56: 3875–3878.
Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D. . 1995 Nature Med. 1: 686–692.
Messing EM and Catalona W. . 1998 Urothelial tumors of the urinary tract. In: Campbell's Urology (7th Edn.). Walsh PC, Retik AB, Vaughan Jr. ED and Wein AJ (eds.).. WB Saunders Co.: Philadelphia pp. 2327–2410.
Mostofi FK, Sobin LH and Torloni H. . 1973 Histological Typing of Urinary Bladder Tumours. WHO: Geneva.
Muto S, Horie SK, Takahashi S, Tomita K and Kitamura T. . 2000 Cancer Res. 60: 4021–4025.
Nishiyama H, Takahashi T, Kakehi Y, Habuchi T and Knowles MA. . 1999 Genes Chromosomes Cancer 26: 171–175.
Sakai T, Toguchida J, Ohtani N, Yandell DW, Rapaport JM and Dryja TP. . 1991 Am. J. Hum. Genet. 48: 880–888.
Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC and Vogelstein B. . 1992 N. Engl. J. Med. 326: 737–740.
Takahashi T, Habuchi T, Kakehi Y, Mitsumori K, Akao T, Terachi T and Yoshida O. . 1998 Cancer Res. 58: 5835–5841.
Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, Baylin SB and Issa JP. . 1999 Cancer Res. 59: 5438–5442.
UICC (International Union Against Cancer). . 1992 TNM Classification of Malignant Tumors, 4th Ed. Hermanek P and Sobin LH.(eds). Springer-Verlag: Berlin, Germany.
van Tilborg AA, Groenfeld LE, van der Kwast TH and Zwarthoff EC. . 1999 Br. J. Cancer 80: 489–494.
Acknowledgements
This work is supported by Grants-in-Aid (B12470327, B10470331, B10470330, B09557129, B10470336) from the Ministry of Education, Science, Sports and Culture of Japan.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Habuchi, T., Takahashi, T., Kakinuma, H. et al. Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer. Oncogene 20, 531–537 (2001). https://doi.org/10.1038/sj.onc.1204122
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204122
Keywords
This article is cited by
-
Long non-coding RNA DBCCR1-003 regulate the expression of DBCCR1 via DNMT1 in bladder cancer
Cancer Cell International (2016)
-
Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression
Modern Pathology (2015)
-
Cloning and characterization of the porcine DBC1 gene encoding deleted in bladder cancer
Molecular Biology Reports (2015)
-
Non-Muscle-Invasive Bladder Cancer in the Elderly Patient
Current Geriatrics Reports (2014)
-
Maintaining the unmethylated state
Clinical Epigenetics (2013)